• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新辅助化疗期间定量超声成像参数的早期变化对局部晚期乳腺癌患者复发的预测作用

Early Changes in Quantitative Ultrasound Imaging Parameters during Neoadjuvant Chemotherapy to Predict Recurrence in Patients with Locally Advanced Breast Cancer.

作者信息

Bhardwaj Divya, Dasgupta Archya, DiCenzo Daniel, Brade Stephen, Fatima Kashuf, Quiaoit Karina, Trudeau Maureen, Gandhi Sonal, Eisen Andrea, Wright Frances, Look-Hong Nicole, Curpen Belinda, Sannachi Lakshmanan, Czarnota Gregory J

机构信息

Physical Sciences, Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.

Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.

出版信息

Cancers (Basel). 2022 Feb 28;14(5):1247. doi: 10.3390/cancers14051247.

DOI:10.3390/cancers14051247
PMID:35267555
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8909335/
Abstract

BACKGROUND

This study was conducted to explore the use of quantitative ultrasound (QUS) in predicting recurrence for patients with locally advanced breast cancer (LABC) early during neoadjuvant chemotherapy (NAC).

METHODS

Eighty-three patients with LABC were scanned with 7 MHz ultrasound before starting NAC (week 0) and during treatment (week 4). Spectral parametric maps were generated corresponding to tumor volume. Twenty-four textural features (QUS-Tex) were determined from parametric maps acquired using grey-level co-occurrence matrices (GLCM) for each patient, which were further processed to generate 64 texture derivatives (QUS-Tex-Tex), leading to a total of 95 features from each time point. Analysis was carried out on week 4 data and compared to baseline (week 0) data. ∆Week 4 data was obtained from the difference in QUS parameters, texture features (QUS-Tex), and texture derivatives (QUS-Tex-Tex) of week 4 data and week 0 data. Patients were divided into two groups: recurrence and non-recurrence. Machine learning algorithms using -nearest neighbor (k-NN) and support vector machines (SVMs) were used to generate radiomic models. Internal validation was undertaken using leave-one patient out cross-validation method.

RESULTS

With a median follow up of 69 months (range 7-118 months), 28 patients had disease recurrence. The k-NN classifier was the best performing algorithm at week 4 with sensitivity, specificity, accuracy, and area under curve (AUC) of 87%, 75%, 81%, and 0.83, respectively. The inclusion of texture derivatives (QUS-Tex-Tex) in week 4 QUS data analysis led to the improvement of the classifier performances. The AUC increased from 0.70 (0.59 to 0.79, 95% confidence interval) without texture derivatives to 0.83 (0.73 to 0.92) with texture derivatives. The most relevant features separating the two groups were higher-order texture derivatives obtained from scatterer diameter and acoustic concentration-related parametric images.

CONCLUSIONS

This is the first study highlighting the utility of QUS radiomics in the prediction of recurrence during the treatment of LABC. It reflects that the ongoing treatment-related changes can predict clinical outcomes with higher accuracy as compared to pretreatment features alone.

摘要

背景

本研究旨在探讨定量超声(QUS)在新辅助化疗(NAC)早期预测局部晚期乳腺癌(LABC)患者复发情况中的应用。

方法

83例LABC患者在开始NAC前(第0周)和治疗期间(第4周)接受7MHz超声扫描。生成与肿瘤体积对应的频谱参数图。从每位患者使用灰度共生矩阵(GLCM)获取的参数图中确定24个纹理特征(QUS-Tex),进一步处理这些特征以生成64个纹理衍生特征(QUS-Tex-Tex),每个时间点共有95个特征。对第4周的数据进行分析,并与基线(第0周)数据进行比较。第4周数据的∆是通过第4周数据和第0周数据的QUS参数、纹理特征(QUS-Tex)和纹理衍生特征(QUS-Tex-Tex)的差异获得的。患者分为两组:复发组和非复发组。使用k近邻(k-NN)和支持向量机(SVM)的机器学习算法生成放射组学模型。采用留一患者交叉验证法进行内部验证。

结果

中位随访69个月(范围7-118个月),28例患者疾病复发。k-NN分类器在第4周是表现最佳的算法,其灵敏度、特异度、准确度和曲线下面积(AUC)分别为87%、75%、81%和0.83。在第4周的QUS数据分析中纳入纹理衍生特征(QUS-Tex-Tex)可提高分类器性能。AUC从无纹理衍生特征时的0.70(0.59至0.79,95%置信区间)增加到有纹理衍生特征时的0.83(0.73至0.92)。区分两组的最相关特征是从散射体直径和声浓度相关参数图像获得的高阶纹理衍生特征。

结论

这是第一项强调QUS放射组学在LABC治疗期间预测复发实用性的研究。它表明,与单独的治疗前特征相比,正在进行的与治疗相关的变化能够更准确地预测临床结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0797/8909335/ba0d62e8c86e/cancers-14-01247-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0797/8909335/f27776760bb9/cancers-14-01247-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0797/8909335/9afdfeecfe76/cancers-14-01247-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0797/8909335/872c27c48849/cancers-14-01247-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0797/8909335/ba0d62e8c86e/cancers-14-01247-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0797/8909335/f27776760bb9/cancers-14-01247-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0797/8909335/9afdfeecfe76/cancers-14-01247-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0797/8909335/872c27c48849/cancers-14-01247-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0797/8909335/ba0d62e8c86e/cancers-14-01247-g004.jpg

相似文献

1
Early Changes in Quantitative Ultrasound Imaging Parameters during Neoadjuvant Chemotherapy to Predict Recurrence in Patients with Locally Advanced Breast Cancer.新辅助化疗期间定量超声成像参数的早期变化对局部晚期乳腺癌患者复发的预测作用
Cancers (Basel). 2022 Feb 28;14(5):1247. doi: 10.3390/cancers14051247.
2
Quantitative ultrasound radiomics using texture derivatives in prediction of treatment response to neo-adjuvant chemotherapy for locally advanced breast cancer.使用纹理导数的定量超声放射组学在预测局部晚期乳腺癌新辅助化疗治疗反应中的应用
Oncotarget. 2020 Oct 20;11(42):3782-3792. doi: 10.18632/oncotarget.27742.
3
Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi-institutional study.定量超声放射组学预测局部晚期乳腺癌患者新辅助化疗反应的多中心研究结果。
Cancer Med. 2020 Aug;9(16):5798-5806. doi: 10.1002/cam4.3255. Epub 2020 Jun 29.
4
Quantitative ultrasound radiomics for therapy response monitoring in patients with locally advanced breast cancer: Multi-institutional study results.定量超声放射组学在局部晚期乳腺癌患者治疗反应监测中的应用:多机构研究结果。
PLoS One. 2020 Jul 27;15(7):e0236182. doi: 10.1371/journal.pone.0236182. eCollection 2020.
5
Ultrasound delta-radiomics during radiotherapy to predict recurrence in patients with head and neck squamous cell carcinoma.放疗期间超声影像组学预测头颈部鳞状细胞癌患者复发情况
Clin Transl Radiat Oncol. 2021 Mar 12;28:62-70. doi: 10.1016/j.ctro.2021.03.002. eCollection 2021 May.
6
Radiomics in predicting recurrence for patients with locally advanced breast cancer using quantitative ultrasound.基于定量超声的影像组学在预测局部晚期乳腺癌患者复发中的应用
Oncotarget. 2021 Dec 7;12(25):2437-2448. doi: 10.18632/oncotarget.28139.
7
prediction of response in multicentre locally advanced breast cancer (LABC) patients using quantitative ultrasound and derivative texture methods.使用定量超声和衍生纹理方法预测多中心局部晚期乳腺癌(LABC)患者的反应
Oncotarget. 2021 Jan 19;12(2):81-94. doi: 10.18632/oncotarget.27867.
8
Quantitative ultrasound assessment of breast tumor response to chemotherapy using a multi-parameter approach.使用多参数方法对乳腺癌化疗反应进行定量超声评估。
Oncotarget. 2016 Jul 19;7(29):45094-45111. doi: 10.18632/oncotarget.8862.
9
Comparison of methods for texture analysis of QUS parametric images in the characterization of breast lesions.用于乳腺病变特征描述的定量超声(QUS)参数图像纹理分析方法的比较
PLoS One. 2020 Dec 31;15(12):e0244965. doi: 10.1371/journal.pone.0244965. eCollection 2020.
10
Response monitoring of breast cancer patients receiving neoadjuvant chemotherapy using quantitative ultrasound, texture, and molecular features.使用定量超声、纹理和分子特征对接受新辅助化疗的乳腺癌患者进行反应监测。
PLoS One. 2018 Jan 3;13(1):e0189634. doi: 10.1371/journal.pone.0189634. eCollection 2018.

引用本文的文献

1
Validation of a Quantitative Ultrasound Texture Analysis Model for Early Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer: A Prospective Serial Imaging Study.用于早期预测乳腺癌新辅助化疗反应的定量超声纹理分析模型的验证:一项前瞻性系列成像研究
Cancers (Basel). 2025 Aug 7;17(15):2594. doi: 10.3390/cancers17152594.
2
Prediction of Chemotherapy Response in Locally Advanced Breast Cancer Patients at Pre-Treatment Using CT Textural Features and Machine Learning: Comparison of Feature Selection Methods.使用CT纹理特征和机器学习对局部晚期乳腺癌患者治疗前化疗反应进行预测:特征选择方法的比较
Tomography. 2025 Mar 13;11(3):33. doi: 10.3390/tomography11030033.
3

本文引用的文献

1
Radiomics in predicting recurrence for patients with locally advanced breast cancer using quantitative ultrasound.基于定量超声的影像组学在预测局部晚期乳腺癌患者复发中的应用
Oncotarget. 2021 Dec 7;12(25):2437-2448. doi: 10.18632/oncotarget.28139.
2
Ultrasound delta-radiomics during radiotherapy to predict recurrence in patients with head and neck squamous cell carcinoma.放疗期间超声影像组学预测头颈部鳞状细胞癌患者复发情况
Clin Transl Radiat Oncol. 2021 Mar 12;28:62-70. doi: 10.1016/j.ctro.2021.03.002. eCollection 2021 May.
3
Assessment of clinical radiosensitivity in patients with head-neck squamous cell carcinoma from pre-treatment quantitative ultrasound radiomics.
Harnessing artificial intelligence for predicting breast cancer recurrence: a systematic review of clinical and imaging data.
利用人工智能预测乳腺癌复发:对临床和影像数据的系统综述
Discov Oncol. 2025 Feb 8;16(1):135. doi: 10.1007/s12672-025-01908-6.
4
Delta radiomics: an updated systematic review.德尔塔放射组学:一项更新的系统评价。
Radiol Med. 2024 Aug;129(8):1197-1214. doi: 10.1007/s11547-024-01853-4. Epub 2024 Jul 17.
5
Development of a multiparametric model for predicting the response to neoadjuvant chemotherapy in breast cancer.用于预测乳腺癌新辅助化疗反应的多参数模型的开发。
Transl Cancer Res. 2024 Feb 29;13(2):558-568. doi: 10.21037/tcr-23-770. Epub 2024 Feb 22.
6
Potential added value of computed tomography radiomics to multimodal prediction models for benign and malignant breast tumors.计算机断层扫描影像组学对乳腺良恶性肿瘤多模态预测模型的潜在附加价值。
Transl Cancer Res. 2024 Jan 31;13(1):317-329. doi: 10.21037/tcr-23-1042. Epub 2024 Jan 15.
7
Predictive value of machine learning for breast cancer recurrence: a systematic review and meta-analysis.机器学习对乳腺癌复发的预测价值:系统评价和荟萃分析。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10659-10674. doi: 10.1007/s00432-023-04967-w. Epub 2023 Jun 11.
8
Clinical-radiomics models based on plain X-rays for prediction of lung metastasis in patients with osteosarcoma.基于普通 X 射线的临床放射组学模型预测骨肉瘤患者的肺转移。
BMC Med Imaging. 2023 Mar 23;23(1):40. doi: 10.1186/s12880-023-00991-x.
9
Artificial intelligence assists precision medicine in cancer treatment.人工智能助力癌症治疗中的精准医疗。
Front Oncol. 2023 Jan 4;12:998222. doi: 10.3389/fonc.2022.998222. eCollection 2022.
10
Implementation of Non-Invasive Quantitative Ultrasound in Clinical Cancer Imaging.非侵入性定量超声在临床癌症成像中的应用
Cancers (Basel). 2022 Dec 16;14(24):6217. doi: 10.3390/cancers14246217.
基于治疗前定量超声放射组学评估头颈部鳞状细胞癌患者的临床放射敏感性。
Sci Rep. 2021 Mar 17;11(1):6117. doi: 10.1038/s41598-021-85221-6.
4
prediction of response in multicentre locally advanced breast cancer (LABC) patients using quantitative ultrasound and derivative texture methods.使用定量超声和衍生纹理方法预测多中心局部晚期乳腺癌(LABC)患者的反应
Oncotarget. 2021 Jan 19;12(2):81-94. doi: 10.18632/oncotarget.27867.
5
Quantitative ultrasound radiomics in predicting recurrence for patients with node-positive head-neck squamous cell carcinoma treated with radical radiotherapy.定量超声放射组学预测接受根治性放疗的颈部淋巴结阳性头颈部鳞状细胞癌患者复发的价值
Cancer Med. 2021 Apr;10(8):2579-2589. doi: 10.1002/cam4.3634. Epub 2020 Dec 13.
6
Quantitative ultrasound radiomics using texture derivatives in prediction of treatment response to neo-adjuvant chemotherapy for locally advanced breast cancer.使用纹理导数的定量超声放射组学在预测局部晚期乳腺癌新辅助化疗治疗反应中的应用
Oncotarget. 2020 Oct 20;11(42):3782-3792. doi: 10.18632/oncotarget.27742.
7
Quantitative ultrasound radiomics for therapy response monitoring in patients with locally advanced breast cancer: Multi-institutional study results.定量超声放射组学在局部晚期乳腺癌患者治疗反应监测中的应用:多机构研究结果。
PLoS One. 2020 Jul 27;15(7):e0236182. doi: 10.1371/journal.pone.0236182. eCollection 2020.
8
Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi-institutional study.定量超声放射组学预测局部晚期乳腺癌患者新辅助化疗反应的多中心研究结果。
Cancer Med. 2020 Aug;9(16):5798-5806. doi: 10.1002/cam4.3255. Epub 2020 Jun 29.
9
Overview of radiomics in breast cancer diagnosis and prognostication.乳腺癌诊断和预后中的放射组学概述。
Breast. 2020 Feb;49:74-80. doi: 10.1016/j.breast.2019.10.018. Epub 2019 Nov 6.
10
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial.21 基因复发评分在 26 到 100 之间的早期乳腺癌患者接受辅助化疗加内分泌治疗的临床结局:TAILORx 随机临床试验的二次分析。
JAMA Oncol. 2020 Mar 1;6(3):367-374. doi: 10.1001/jamaoncol.2019.4794.